Stonepine Capital Management LLC Invests $724,000 in Surrozen, Inc. (NASDAQ:SRZN)

Stonepine Capital Management LLC purchased a new stake in Surrozen, Inc. (NASDAQ:SRZN) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 66,084 shares of the company’s stock, valued at approximately $724,000. Surrozen accounts for about 0.7% of Stonepine Capital Management LLC’s holdings, making the stock its 18th largest holding. Stonepine Capital Management LLC owned approximately 2.07% of Surrozen at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the business. Nantahala Capital Management LLC purchased a new stake in shares of Surrozen during the 2nd quarter valued at about $2,050,000. CVI Holdings LLC acquired a new stake in Surrozen during the second quarter valued at approximately $711,000. Finally, Armistice Capital LLC bought a new position in Surrozen during the second quarter worth $2,080,000. Hedge funds and other institutional investors own 66.57% of the company’s stock.

Surrozen Stock Up 16.9 %

NASDAQ SRZN opened at $11.98 on Tuesday. The company has a 50-day simple moving average of $8.53 and a 200-day simple moving average of $9.95. Surrozen, Inc. has a one year low of $4.50 and a one year high of $16.19.

Surrozen (NASDAQ:SRZN) last announced its quarterly earnings results on Monday, August 12th. The company reported ($1.54) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.79) by $1.25. As a group, equities analysts anticipate that Surrozen, Inc. will post -9.49 earnings per share for the current year.

Surrozen Profile

Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.